CDC MPT FUNDS
NSAR-B, EX-27, 2000-12-28
Previous: CDC MPT FUNDS, NSAR-B, EX-27, 2000-12-28
Next: CDC MPT FUNDS, NSAR-B, EX-27, 2000-12-28



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0001072029
<NAME> CDC MPT+ FUNDS
<SERIES>
   <NUMBER> 012
   <NAME> CDC MPT+ AGGRESIVE EQUITY FUND INSTITUTIONAL SHARES

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             NOV-01-1999
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                         31490808
<INVESTMENTS-AT-VALUE>                        32751282
<RECEIVABLES>                                   226890
<ASSETS-OTHER>                                  970801
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                33948973
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                       162549
<TOTAL-LIABILITIES>                             162549
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                      32121098
<SHARES-COMMON-STOCK>                          3224341
<SHARES-COMMON-PRIOR>                          2544020
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                         484548
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                       1180778
<NET-ASSETS>                                  33786424
<DIVIDEND-INCOME>                               355303
<INTEREST-INCOME>                               195007
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                (985779)
<NET-INVESTMENT-INCOME>                       (435469)
<REALIZED-GAINS-CURRENT>                        864607
<APPREC-INCREASE-CURRENT>                      1212815
<NET-CHANGE-FROM-OPS>                          1641953
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                      (327705)
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        7001578
<NUMBER-OF-SHARES-REDEEMED>                   (445986)
<SHARES-REINVESTED>                             230649
<NET-CHANGE-IN-ASSETS>                         8100488
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                       273990
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                           864625
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                1265579
<AVERAGE-NET-ASSETS>                          34625409
<PER-SHARE-NAV-BEGIN>                            10.10
<PER-SHARE-NII>                                 (0.14)
<PER-SHARE-GAIN-APPREC>                           0.62
<PER-SHARE-DIVIDEND>                              0.00
<PER-SHARE-DISTRIBUTIONS>                       (0.10)
<RETURNS-OF-CAPITAL>                              0.00
<PER-SHARE-NAV-END>                              10.48
<EXPENSE-RATIO>                                   2.85


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission